【缺氧疗法生物科技公司NuvOx Therapeutics(NUOX.US)申请美股IPO,拟募资2000万美元】智通财经APP获悉,处于临床二期阶段的生物制药企业NuvOx
Therapeutics(NUOX.US)上周五向美国证券交易委员会(SEC)提交首次公开募股(IPO)申请,计划融资最高2000万美元。该公司专注于开发以改善组织缺氧为目标的氧疗药物。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.